Research output per year
Research output per year
Personal profile
Research interests
My research focuses on the identification of tumor specific mutant antigens recognized by the immune system as foreign that serve as the target of a T-cell response against tumors. We take advantage of cancer genomics and bioinformatics techniques to detect tumor-specific mutations that accumulate during transformation and use this information to predict which mutations are potentially antigenic.
Clinical interests
Cancer/tumor immunotherapy
Fingerprint
Dive into the research topics where Jeffrey Ward is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer
Knapp, B., Mezquita, L., Devarakonda, S., Aldea, M., Waqar, S. N., Pepin, K., Ward, J., Botticella, A., Howarth, K., Knape, C., Morris, C., Govindan, R., Besse, B. & Morgensztern, D., Mar 28 2022, In: Frontiers in Oncology. 12, 856132.Research output: Contribution to journal › Article › peer-review
Open Access -
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma
Ward, J. P., Berrien-Elliott, M. M., Gomez, F., Luo, J., Becker-Hapak, M., Cashen, A. F., Wagner-Johnston, N. D., Maddocks, K., Mosior, M., Foster, M., Krysiak, K., Schmidt, A., Skidmore, Z. L., Desai, S., Watkins, M. P., Fischer, A., Griffith, M., Griffith, O. L., Fehniger, T. A. & Bartlett, N. L., Mar 31 2022, In: Blood. 139, 13, p. 1999-2010 12 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Tumor Infiltrating Lymphocytes (TIL): From Bench to Bedside
Ward, J. P., 2022, Cancer Drug Discovery and Development. Humana Press Inc., p. 223-248 26 p. (Cancer Drug Discovery and Development).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Bcl6-independent in vivo development of functional type 1 classical dendritic cells supporting tumor rejection
Bagadia, P., O'Connor, K. W., Wu, R., Ferris, S. T., Ward, J. P., Schreiber, R. D., Murphy, T. L. & Murphy, K. M., Jul 1 2021, In: Journal of Immunology. 207, 1, p. 125-132 8 p.Research output: Contribution to journal › Article › peer-review
-
Genomic Profiling of Lung Adenocarcinoma in Never-Smokers
Devarakonda, S., Li, Y., Martins Rodrigues, F., Sankararaman, S., Kadara, H., Goparaju, C., Lanc, I., Pepin, K., Waqar, S. N., Morgensztern, D., Ward, J., Masood, A., Fulton, R., Fulton, L., Gillette, M. A., Satpathy, S., Carr, S. A., Wistuba, I., Pass, H., Wilson, R. K. & 2 others, , Nov 20 2021, In: Journal of Clinical Oncology. 39, 33, p. 3747-3758 12 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations